Vertex Pharmaceuticals Incorporated
לונג

VRTX Long

All risks already in price IMO. Short downtrend most probably soon will change to bullish as fundamental improves.
Triger: latest news about ABBV & Galapagos Phase 2 study in CF

כתב ויתור